Analyst Craig Hettenbach of Morgan Stanley maintained a Hold rating on HCA Healthcare (HCA – Research Report), retaining the price target of ...

HCA Healthcare Inc. closed $111.35 short of its 52-week high ($417.14), which the company reached on October 18th.

Bernstein analyst Lance Wilkes maintained a Hold rating on HCA Healthcare (HCA – Research Report) yesterday and set a price target of $331.00.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Improving the Patient Financial Experience Throughout the Patient Journey While many healthcare providers believe that improving the patient financial experience is a critical step for their ...

Current price $309.44 52-week high $417.14 ...

After hours: 7:49:21 p.m. EST ...